Insights

The Insights page consists of Insight Articles, Commentaries, C-level Q&As, Discussion Group Reports, and Survey Reports.

Insight Article
At 2021’s Biologics Europe: Online, we sat down with an advisory group of leading industry experts to hear their thoughts on the state of the Biologic drug industry and the potential of Biotherapeutic manufacturing. Biologics engineering is a rapidly evolving field, and 2022 looks to be a year of exciting technological and strategy breakthroughs.
By Tia Byer |
20 August 2021
Proteins & Antibodies
Insight Article
2020 and 2021 has been dominated by headlines about the COVID inoculation programme and its tremendous success. But what’s next for the vaccine?
By Tia Byer |
16 August 2021
Vaccines
Insight Article
Andre Cobb, Senior Lecture in Organic Chemistry, King’s College London. Date of Congress: 27th - 29th April 2020
02 January 2020
Peptides
Insight Article
Dr. Philip Webber, Patent Attorney, Dehns Patent and Trade Mark Attorneys
16 April 2018
Biosimilars & Biobetters
Insight Article
Janice M. Reichert, PH.D., Executive Director, The Antibody Society& Editor-in-Chief, mAbs
16 April 2018
Proteins & Antibodies
Insight Article
Gregory J. Glover, Attorney at Law, Pharmaceutical Law Group PC
16 April 2018
Biosimilars & Biobetters
Advertisement

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biologics

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.